US Stock MarketDetailed Quotes

BTTX Better Therapeutics

Watchlist
  • 0.000
  • +0.000+9900.00%
15min DelayClose Nov 27 16:00 ET
5.45KMarket Cap0.00P/E (TTM)

Better Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-51.43%5.34M
-26.82%7.03M
-4.49%8.93M
25.20%38.26M
-31.25%8.32M
22.25%11M
48.27%9.6M
212.86%9.35M
382.70%30.56M
12.1M
Selling and administrative expenses
-36.44%3.51M
-10.69%4.79M
-2.40%5.54M
96.17%21.82M
-8.30%5.27M
137.07%5.52M
273.12%5.36M
252.52%5.67M
316.47%11.12M
--5.75M
-Selling and marketing expense
-10.60%1.39M
1.25%1.7M
2.94%2.1M
198.76%6.98M
44.01%1.7M
182.07%1.56M
198.40%1.68M
4,653.49%2.04M
981.48%2.34M
--1.18M
-General and administrative expense
-46.59%2.12M
-16.16%3.08M
-5.40%3.43M
68.90%14.84M
-21.76%3.58M
123.09%3.96M
321.44%3.68M
131.67%3.63M
257.96%8.79M
--4.57M
Research and development costs
-66.53%1.83M
-47.18%2.24M
-7.73%3.39M
-15.41%16.44M
-52.01%3.05M
-17.85%5.48M
-15.82%4.24M
166.55%3.67M
431.04%19.44M
--6.35M
Operating profit
51.43%-5.34M
26.82%-7.03M
4.49%-8.93M
-25.20%-38.26M
31.25%-8.32M
-22.25%-11M
-48.27%-9.6M
-212.86%-9.35M
-383.31%-30.56M
-12.1M
Net non-operating interest income expense
-27.59%-518K
-71.12%-563K
-35.96%-431K
-705.95%-1.49M
-141.21%-439K
-406K
-32,800.00%-329K
-15,750.00%-317K
-85.00%-185K
-182K
Non-operating interest expense
27.59%518K
71.12%563K
35.96%431K
705.95%1.49M
141.21%439K
--406K
32,800.00%329K
15,750.00%317K
85.00%185K
--182K
Other net income (expense)
-5,255.03%-9.74M
-1.61M
Gain on sale of security
----
----
----
----
----
----
----
----
-5,597.35%-10.39M
---1.61M
Special income (charges)
----
----
----
--0
----
----
----
----
--647K
--0
-Less:Other special charges
----
----
----
----
----
----
----
----
---647K
--0
Income before tax
48.61%-5.86M
23.57%-7.59M
3.17%-9.36M
1.82%-39.75M
36.96%-8.76M
8.50%-11.4M
-14.79%-9.93M
-76.28%-9.66M
-549.47%-40.49M
-13.9M
Income tax
0.00%3K
1K
1K
104.58%7K
233.33%4K
3K
0
0
-200.00%-153K
-3K
Net income
48.60%-5.86M
23.56%-7.59M
3.16%-9.36M
1.43%-39.76M
36.92%-8.77M
8.47%-11.41M
-14.77%-9.93M
-81.28%-9.66M
-531.52%-40.34M
-13.89M
Net income continuous Operations
48.60%-5.86M
23.56%-7.59M
3.16%-9.36M
1.43%-39.76M
36.92%-8.77M
8.47%-11.41M
-14.77%-9.93M
-81.28%-9.66M
-531.52%-40.34M
---13.89M
Minority interest income
Net income attributable to the parent company
48.60%-5.86M
23.56%-7.59M
3.16%-9.36M
1.43%-39.76M
36.92%-8.77M
8.47%-11.41M
-14.77%-9.93M
-81.28%-9.66M
-531.52%-40.34M
-13.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
48.60%-5.86M
23.56%-7.59M
3.16%-9.36M
1.43%-39.76M
31.03%-8.77M
11.34%-11.41M
-9.77%-9.93M
-68.98%-9.66M
-410.96%-40.34M
-12.71M
Basic earnings per share
68.75%-0.15
42.86%-0.24
4.88%-0.39
45.66%-1.69
47.89%-0.37
11.94%-0.48
-9.60%-0.42
-69.22%-0.41
-829.76%-3.11
-0.71
Diluted earnings per share
68.75%-0.15
42.86%-0.24
4.88%-0.39
45.66%-1.69
47.89%-0.37
11.94%-0.48
-9.60%-0.42
-69.22%-0.41
-829.76%-3.11
-0.71
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -51.43%5.34M-26.82%7.03M-4.49%8.93M25.20%38.26M-31.25%8.32M22.25%11M48.27%9.6M212.86%9.35M382.70%30.56M12.1M
Selling and administrative expenses -36.44%3.51M-10.69%4.79M-2.40%5.54M96.17%21.82M-8.30%5.27M137.07%5.52M273.12%5.36M252.52%5.67M316.47%11.12M--5.75M
-Selling and marketing expense -10.60%1.39M1.25%1.7M2.94%2.1M198.76%6.98M44.01%1.7M182.07%1.56M198.40%1.68M4,653.49%2.04M981.48%2.34M--1.18M
-General and administrative expense -46.59%2.12M-16.16%3.08M-5.40%3.43M68.90%14.84M-21.76%3.58M123.09%3.96M321.44%3.68M131.67%3.63M257.96%8.79M--4.57M
Research and development costs -66.53%1.83M-47.18%2.24M-7.73%3.39M-15.41%16.44M-52.01%3.05M-17.85%5.48M-15.82%4.24M166.55%3.67M431.04%19.44M--6.35M
Operating profit 51.43%-5.34M26.82%-7.03M4.49%-8.93M-25.20%-38.26M31.25%-8.32M-22.25%-11M-48.27%-9.6M-212.86%-9.35M-383.31%-30.56M-12.1M
Net non-operating interest income expense -27.59%-518K-71.12%-563K-35.96%-431K-705.95%-1.49M-141.21%-439K-406K-32,800.00%-329K-15,750.00%-317K-85.00%-185K-182K
Non-operating interest expense 27.59%518K71.12%563K35.96%431K705.95%1.49M141.21%439K--406K32,800.00%329K15,750.00%317K85.00%185K--182K
Other net income (expense) -5,255.03%-9.74M-1.61M
Gain on sale of security ---------------------------------5,597.35%-10.39M---1.61M
Special income (charges) --------------0------------------647K--0
-Less:Other special charges -----------------------------------647K--0
Income before tax 48.61%-5.86M23.57%-7.59M3.17%-9.36M1.82%-39.75M36.96%-8.76M8.50%-11.4M-14.79%-9.93M-76.28%-9.66M-549.47%-40.49M-13.9M
Income tax 0.00%3K1K1K104.58%7K233.33%4K3K00-200.00%-153K-3K
Net income 48.60%-5.86M23.56%-7.59M3.16%-9.36M1.43%-39.76M36.92%-8.77M8.47%-11.41M-14.77%-9.93M-81.28%-9.66M-531.52%-40.34M-13.89M
Net income continuous Operations 48.60%-5.86M23.56%-7.59M3.16%-9.36M1.43%-39.76M36.92%-8.77M8.47%-11.41M-14.77%-9.93M-81.28%-9.66M-531.52%-40.34M---13.89M
Minority interest income
Net income attributable to the parent company 48.60%-5.86M23.56%-7.59M3.16%-9.36M1.43%-39.76M36.92%-8.77M8.47%-11.41M-14.77%-9.93M-81.28%-9.66M-531.52%-40.34M-13.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 48.60%-5.86M23.56%-7.59M3.16%-9.36M1.43%-39.76M31.03%-8.77M11.34%-11.41M-9.77%-9.93M-68.98%-9.66M-410.96%-40.34M-12.71M
Basic earnings per share 68.75%-0.1542.86%-0.244.88%-0.3945.66%-1.6947.89%-0.3711.94%-0.48-9.60%-0.42-69.22%-0.41-829.76%-3.11-0.71
Diluted earnings per share 68.75%-0.1542.86%-0.244.88%-0.3945.66%-1.6947.89%-0.3711.94%-0.48-9.60%-0.42-69.22%-0.41-829.76%-3.11-0.71
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday+1.25%